Quantifying the Real-world Side Effects of FDA-approved Immunotherapy Drugs in NMSC
Immunotherapy medications are now available for treating non-melanoma skin cancers (NMSC) including basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). While these medications have expanded treatment options for non-melanoma skin cancers, they are not without their share of side effects. Medication labels do provide a list of side effects, but researchers set out characterize […]